Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.
Muñoz-Culla M, Irizar H, Castillo-Triviño T, Sáenz-Cuesta M, Sepúlveda L, Lopetegi I, López de Munain A, Olascoaga J, Baranzini SE, Otaegui D. Muñoz-Culla M, et al. Among authors: baranzini se. Mult Scler. 2014 Dec;20(14):1851-9. doi: 10.1177/1352458514534513. Epub 2014 May 22. Mult Scler. 2014. PMID: 24852919
Genomics and new targets for multiple sclerosis.
Baranzini SE, Oksenberg JR. Baranzini SE, et al. Pharmacogenomics. 2005 Mar;6(2):151-61. doi: 10.1517/14622416.6.2.151. Pharmacogenomics. 2005. PMID: 15882133 Review.
Differential micro RNA expression in PBMC from multiple sclerosis patients.
Otaegui D, Baranzini SE, Armañanzas R, Calvo B, Muñoz-Culla M, Khankhanian P, Inza I, Lozano JA, Castillo-Triviño T, Asensio A, Olaskoaga J, López de Munain A. Otaegui D, et al. Among authors: baranzini se. PLoS One. 2009 Jul 20;4(7):e6309. doi: 10.1371/journal.pone.0006309. PLoS One. 2009. PMID: 19617918 Free PMC article.
The genetics of multiple sclerosis: an up-to-date review.
Gourraud PA, Harbo HF, Hauser SL, Baranzini SE. Gourraud PA, et al. Among authors: baranzini se. Immunol Rev. 2012 Jul;248(1):87-103. doi: 10.1111/j.1600-065X.2012.01134.x. Immunol Rev. 2012. PMID: 22725956 Free PMC article. Review.
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients.
Baranzini SE, Madireddy LR, Cromer A, D'Antonio M, Lehr L, Beelke M, Farmer P, Battaglini M, Caillier SJ, Stromillo ML, De Stefano N, Monnet E, Cree BA. Baranzini SE, et al. Mult Scler. 2015 Jun;21(7):894-904. doi: 10.1177/1352458514555786. Epub 2014 Nov 12. Mult Scler. 2015. PMID: 25392319 Clinical Trial.
200 results